Stay updated on Selonsertib for NASH F3 Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selonsertib for NASH F3 Fibrosis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study record page now displays a “TypeError: Failed to fetch” message instead of a 403 error response. A temporary NIH transition notice is no longer shown.
    Difference
    1%
    Check dated 2026-11-09T13:18:26.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T12:54:58.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says that some content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).
    Difference
    1%
    Check dated 2026-10-26T14:17:57.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer’s revision label changed from v3.7.1 to v3.7.2, while the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:11:02.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-12T15:12:04.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The study page displays a 403 Forbidden message with a Home link in place of study content.
    Difference
    0.5%
    Check dated 2026-10-05T14:59:23.000Z thumbnail image

Stay in the know with updates to Selonsertib for NASH F3 Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.